Literature DB >> 19837691

Co-evolution of KIR2DL3 with HLA-C in a human population retaining minimal essential diversity of KIR and HLA class I ligands.

Ketevan Gendzekhadze1, Paul J Norman, Laurent Abi-Rached, Thorsten Graef, Achim K Moesta, Zulay Layrisse, Peter Parham.   

Abstract

Natural killer (NK) cells contribute to immunity and reproduction. Guiding these functions, and NK cell education, are killer cell Ig-like receptors (KIR), NK cell receptors that recognize HLA class I. In most human populations, these highly polymorphic receptors and ligands combine with extraordinary diversity. To assess how much of this diversity is necessary, we studied KIR and HLA class I at high resolution in the Yucpa, a small South Amerindian population that survived an approximate 15,000-year history of population bottleneck and epidemic infection, including recent viral hepatitis. The Yucpa retain the three major HLA epitopes recognized by KIR. Through balancing selection on a few divergent haplotypes the Yucpa maintain much of the KIR variation found worldwide. HLA-C*07, the strongest educator of C1-specific NK cells, has reached unusually high frequency in the Yucpa. Concomitantly, weaker variants of the C1 receptor, KIR2DL3, were selected and have largely replaced the form of KIR2DL3 brought by the original migrants from Asia. HLA-C1 and KIR2DL3 homozygosity has previously been correlated with resistance to viral hepatitis. Selection of weaker forms of KIR2DL3 in the Yucpa can be seen as compensation for the high frequency of the potent HLA-C*07 ligand. This study provides an estimate of the minimal KIR-HLA system essential for long-term survival of a human population. That it contains all functional elements of KIR diversity worldwide, attests to the competitive advantage it provides, not only for surviving epidemic infections, but also for rebuilding populations once infection has passed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19837691      PMCID: PMC2774017          DOI: 10.1073/pnas.0906051106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  48 in total

1.  Generating samples under a Wright-Fisher neutral model of genetic variation.

Authors:  Richard R Hudson
Journal:  Bioinformatics       Date:  2002-02       Impact factor: 6.937

Review 2.  Genetic and functional relationships between MHC and NK receptor genes.

Authors:  J Trowsdale
Journal:  Immunity       Date:  2001-09       Impact factor: 31.745

3.  Extended HLA haplotypes in a Carib Amerindian population: the Yucpa of the Perija Range.

Authors:  Z Layrisse; Y Guedez; E Domínguez; N Paz; S Montagnani; M Matos; F Herrera; V Ogando; O Balbas; A Rodríguez-Larralde
Journal:  Hum Immunol       Date:  2001-09       Impact factor: 2.850

4.  New allele frequency database: http://www.allelefrequencies.net.

Authors:  D Middleton; L Menchaca; H Rood; R Komerofsky
Journal:  Tissue Antigens       Date:  2003-05

5.  Different NK cell surface phenotypes defined by the DX9 antibody are due to KIR3DL1 gene polymorphism.

Authors:  C M Gardiner; L A Guethlein; H G Shilling; M Pando; W H Carr; R Rajalingam; C Vilches; P Parham
Journal:  J Immunol       Date:  2001-03-01       Impact factor: 5.422

6.  Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants.

Authors:  Loredana Ruggeri; Marusca Capanni; Elena Urbani; Katia Perruccio; Warren D Shlomchik; Antonella Tosti; Sabrina Posati; Daniela Rogaia; Francesco Frassoni; Franco Aversa; Massimo F Martelli; Andrea Velardi
Journal:  Science       Date:  2002-03-15       Impact factor: 47.728

Review 7.  Population genetics, history, and health patterns in native americans.

Authors:  Connie J Mulligan; Keith Hunley; Suzanne Cole; Jeffrey C Long
Journal:  Annu Rev Genomics Hum Genet       Date:  2004       Impact factor: 8.929

8.  HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection.

Authors:  Salim I Khakoo; Chloe L Thio; Maureen P Martin; Collin R Brooks; Xiaojiang Gao; Jacquie Astemborski; Jie Cheng; James J Goedert; David Vlahov; Margaret Hilgartner; Steven Cox; Ann-Margeret Little; Graeme J Alexander; Matthew E Cramp; Stephen J O'Brien; William M C Rosenberg; David L Thomas; Mary Carrington
Journal:  Science       Date:  2004-08-06       Impact factor: 47.728

Review 9.  The global impact of pre-eclampsia and eclampsia.

Authors:  Lelia Duley
Journal:  Semin Perinatol       Date:  2009-06       Impact factor: 3.300

10.  Recognition of HLA-A3 and HLA-A11 by KIR3DL2 is peptide-specific.

Authors:  Pokrath Hansasuta; Tao Dong; Hathairat Thananchai; Michael Weekes; Christian Willberg; Hatice Aldemir; Sarah Rowland-Jones; Veronique M Braud
Journal:  Eur J Immunol       Date:  2004-06       Impact factor: 5.532

View more
  63 in total

1.  HLA polymorphism of the Zhuang population reflects the common HLA characteristics among Zhuang-Dong language-speaking populations.

Authors:  Li Shi; Xiao-qin Huang; Lei Shi; Yu-fen Tao; Yu-feng Yao; Liang Yu; Ke-qin Lin; Wen Yi; Hao Sun; Katsushi Tokunaga; Jia-you Chu
Journal:  J Zhejiang Univ Sci B       Date:  2011-06       Impact factor: 3.066

2.  Pregnancy immunogenetics: NK cell education in the womb?

Authors:  Peter Parham; Lisbeth A Guethlein
Journal:  J Clin Invest       Date:  2010-10-25       Impact factor: 14.808

3.  Maternal activating KIRs protect against human reproductive failure mediated by fetal HLA-C2.

Authors:  Susan E Hiby; Richard Apps; Andrew M Sharkey; Lydia E Farrell; Lucy Gardner; Arend Mulder; Frans H Claas; James J Walker; Christopher W Redman; Christopher C Redman; Linda Morgan; Clare Tower; Lesley Regan; Gudrun E Moore; Mary Carrington; Ashley Moffett
Journal:  J Clin Invest       Date:  2010-10-25       Impact factor: 14.808

4.  Polymorphic HLA-C Receptors Balance the Functional Characteristics of KIR Haplotypes.

Authors:  Hugo G Hilton; Lisbeth A Guethlein; Ana Goyos; Neda Nemat-Gorgani; David A Bushnell; Paul J Norman; Peter Parham
Journal:  J Immunol       Date:  2015-08-26       Impact factor: 5.422

Review 5.  Human-specific evolution of killer cell immunoglobulin-like receptor recognition of major histocompatibility complex class I molecules.

Authors:  Peter Parham; Paul J Norman; Laurent Abi-Rached; Lisbeth A Guethlein
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-03-19       Impact factor: 6.237

Review 6.  KIR and HLA under pressure: evidences of coevolution across worldwide populations.

Authors:  Danillo G Augusto; Maria Luiza Petzl-Erler
Journal:  Hum Genet       Date:  2015-06-23       Impact factor: 4.132

7.  KIR2DL4 genetic diversity in a Brazilian population sample: implications for transcription regulation and protein diversity in samples with different ancestry backgrounds.

Authors:  Emiliana Weiss; Heloisa S Andrade; Juliana Rodrigues Lara; Andreia S Souza; Michelle A Paz; Thálitta H A Lima; Iane O P Porto; Nayane S B Silva; Camila F Bannwart Castro; Rejane M T Grotto; Eduardo A Donadi; Celso T Mendes-Junior; Erick C Castelli
Journal:  Immunogenetics       Date:  2021-02-17       Impact factor: 2.846

8.  Different Selected Mechanisms Attenuated the Inhibitory Interaction of KIR2DL1 with C2+ HLA-C in Two Indigenous Human Populations in Southern Africa.

Authors:  Neda Nemat-Gorgani; Hugo G Hilton; Brenna M Henn; Meng Lin; Christopher R Gignoux; Justin W Myrick; Cedric J Werely; Julie M Granka; Marlo Möller; Eileen G Hoal; Makoto Yawata; Nobuyo Yawata; Lies Boelen; Becca Asquith; Peter Parham; Paul J Norman
Journal:  J Immunol       Date:  2018-03-16       Impact factor: 5.422

Review 9.  Co-evolution of MHC class I and variable NK cell receptors in placental mammals.

Authors:  Lisbeth A Guethlein; Paul J Norman; Hugo G Hilton; Peter Parham
Journal:  Immunol Rev       Date:  2015-09       Impact factor: 12.988

10.  Human-specific evolution and adaptation led to major qualitative differences in the variable receptors of human and chimpanzee natural killer cells.

Authors:  Laurent Abi-Rached; Achim K Moesta; Raja Rajalingam; Lisbeth A Guethlein; Peter Parham
Journal:  PLoS Genet       Date:  2010-11-04       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.